Lengthening adalimumab dosing interval in quiescent Crohn's disease patients: protocol for the pragmatic randomised non-inferiority LADI study.
Lisa J T SmitsRenske Wilhelmina Maria PauwelsW KievitD J de JongA C de VriesF HoentjenC J van der Woudenull nullPublished in: BMJ open (2020)
EudraCT registry (2016-003321-42); Clinicaltrials.gov registry (NCT03172377); Dutch trial registry (NTRID6417).